Gossamer Bio, Inc. Common Stock GOSS
$10.73
-5.81%
at last close
Market Cap$65.57 million
P/E Ratio—
Div Yield—
Volume474.2K
52-Week Range
$9.10$309.60
Analyst Ratings
- Consensus
- Moderate Buy — 4 Buy · 2 Hold · 1 Sell (7 analysts)
- Avg. Price Target
- $1.88 (-82.5% downside)
Key Stats
- Today's Range
- $10.47 – $12.52
- 50-Day Range
- $9.10 – $21.46
- 52-Week Range
- $9.10 – $309.60
- Volume
- 474K shs
- Average Volume
- 244K shs
- Market Cap
- $65.57 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- -0.70
- Price / Sales
- —
Short Interest
- Short Interest
- 5.18%
- Days to Cover
- 1.00
About Gossamer Bio, Inc. Common Stock
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Related Stocks
Compare head-to-head: GOSS vs LLY·GOSS vs JNJ·GOSS vs ABBV·GOSS vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.